Cargando…
A combination treatment of low-dose dexamethasone and aspirin-triggered resolvin D1 reduces Sjögren syndrome–like features in a mouse model
BACKGROUND. Sjögren syndrome (SS) is an autoimmune disease characterized by lymphocytic infiltration and diminished secretory function of the salivary glands. Dexamethasone (DEX) resolves dry mouth and lymphocytic infiltration; however, this treatment is difficult to maintain because of multiple adv...
Autores principales: | dos Santos, Harim Tavares, Maslow, Frank, Nam, Kihoon, Trump, Bryan, Weisman, Gary A., Baker, Olga J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448398/ https://www.ncbi.nlm.nih.gov/pubmed/37622089 http://dx.doi.org/10.1016/j.jfscie.2022.100016 |
Ejemplares similares
-
Predictive modeling of aspirin‐triggered resolvin D1 pharmacokinetics for the study of Sjögren's syndrome
por: Yellepeddi, Venkata Kashyap, et al.
Publicado: (2019) -
Laminin-1 Peptides Conjugated to Fibrin Hydrogels Promote Salivary Gland Regeneration in Irradiated Mouse Submandibular Glands
por: Nam, Kihoon, et al.
Publicado: (2021) -
Current experimental methods to investigate the impact of specialized pro-resolving lipid mediators on Sjögren’s syndrome
por: dos Santos, Harim T., et al.
Publicado: (2023) -
Pleiotropic antifibrotic actions of aspirin-triggered resolvin D1 in the lungs
por: Guilherme, Rafael F., et al.
Publicado: (2023) -
Resolvin D1 and Aspirin-Triggered Resolvin D1 Regulate Histamine-stimulated Conjunctival Goblet Cell Secretion
por: Li, Dayu, et al.
Publicado: (2013)